Antibiotic resistance as collateral damage: The tragedy of the commons in a two-disease setting

Mathematical Biosciences

Volumn 263, Issue , 2015, Pages 121-132

  Gao, Daozhou ^a   Lietman, Thomas M ^a,b   Porco, Travis C ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Drug resistance; Game theory; Mass treatment; Targeted treatment; Tragedy of the commons; Two diseases

Indexed keywords

ANTIBIOTICS; CELL PROLIFERATION; GAME THEORY; STRAIN;

ANTIBIOTIC RESISTANCE; BASIC REPRODUCTION NUMBER; CONFLICT OF INTEREST; DRUG RESISTANCE; DRUG-RESISTANT STRAINS; MASS TREATMENT; TARGETED TREATMENT; TRAGEDY OF THE COMMONS;

DISEASES;

ANTIBIOTIC AGENT;

ANTIBIOTIC RESISTANCE; DISEASE TREATMENT; GAME THEORY; INFECTIOUS DISEASE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; COMMUNITY CARE; CONFLICT OF INTEREST; DISEASE MODEL; DRUG USE; EPIDEMIC; INFECTION PREVENTION; MATHEMATICAL ANALYSIS; MATHEMATICAL COMPUTING; MATHEMATICAL MODEL; PNEUMOCOCCAL INFECTION; SOCIAL WELFARE; STREPTOCOCCUS PNEUMONIAE; COMMUNICABLE DISEASES; GAME; HUMAN; THEORETICAL MODEL;

COMMUNICABLE DISEASES; DRUG RESISTANCE, MICROBIAL; GAME THEORY; HUMANS; MODELS, THEORETICAL;

EID: 84926060787     PISSN: 00255564     EISSN: 18793134     Source Type: Journal    
DOI: 10.1016/j.mbs.2015.02.007     Document Type: Article

References (52)

1. Baquero F., Campos J. The tragedy of the commons in antimicrobial chemotherapy. Rev. Esp. Quimioter. 2003, 16(1):11-13.
2. Bhunu C., Garira W., Mukandavire Z. Modeling HIV/AIDS and tuberculosis coinfection. Bull. Math. Biol. 2009, 71(7):1745-1780.
3. Blaser M.J., Falkow S. What are the consequences of the disappearing human microbiota?. Nat. Rev. Microbiol. 2009, 7(12):887-894.
4. Bradley J.S., Byington C.L., Shah S.S., Alverson B., Carter E.R., Harrison C., Kaplan S.L., Mace S.E., McCracken G.H., Moore M.R., St Peter S.D., Stockwell J.A., Swanson J.T. The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. Clin. Infect. Dis. 2011, 53(7):e25-e76.
5. Bremermann H.J., Thieme H.R. A competitive exclusion principle for pathogen virulence. J. Math. Biol. 1989, 27(2):179-190.
6. Cameron D.R., Howden B.P., Peleg A.Y. The interface between antibiotic resistance and virulence in Staphylococcus aureus and its impact upon clinical outcomes. Clin. Infect. Dis. 2011, 53(6):576-582.
7. Cars O., Högberg L.D., Murray M., Nordberg O., Sivaraman S., Lundborg C.S., So A.D., Tomson G. Meeting the challenge of antibiotic resistance. BMJ 2008, 337:a1438.
8. CDC, Mission critical: preventing antibiotic resistance, 2012.
9. Cobey S., Lipsitch M. Niche and neutral effects of acquired immunity permit coexistence of pneumococcal serotypes. Science 2012, 335(6074):1376-1380.
10. Cosner C., Beier J.C., Cantrell R.S., Impoinvil D., Kapitanski L., Potts M.D., Troyo A., Ruan S. The effects of human movement on the persistence of vector-borne diseases. J. Theor. Biol. 2009, 258(4):550-560.
11. D'Agata E.M.C., Webb G.F., Pressley J. Rapid emergence of co-colonization with community-acquired and hospital-acquired methicillin-resistant Staphylococcus aureus strains in the hospital setting. Math. Model. Nat. Phenom. 2010, 5(3):76-93.
12. S.C. Davies, Annual Report of the Chief Medical Officer, Volume Two, 2011, Infections and the Rise of Antimicrobial Resistance, 2013.
13. Dharan N.J., Gubareva L.V., Meyer J.J., Okomo-Adhiambo M., McClinton R.C., Marshall S.A., George K.S., Epperson S., Brammer L., Klimov A.I., Bresee J.S., Fry A.M., Oseltamivir-Resistance Working Group Infections with oseltamivir-resistant influenza A(H1N1) virus in the United States. JAMA 2009, 301(10):1034-1041.
14. Dietz K. Epidemiologic interference of virus populations. J. Math. Biol. 1979, 8(3):291-300.
15. Duan S., Boltz D.A., Seiler P., Li J., Bragstad K., Nielsen L.P., Webby R.J., Webster R.G., Govorkova E.A. Oseltamivir-resistant pandemic H1N1/2009 influenza virus possesses lower transmissibility and fitness in ferrets. PLoS Pathog. 2010, 6(7):e1001022.
16. D. Gao, T.C. Porco, S. Ruan, Coinfection dynamics of two diseases in a single host population, submitted for publication.
17. Gebre T., Ayele B., Zerihun M., House J.I., Stoller N.E., Zhou Z., Ray K.J., Gaynor B.D., Porco T.C., Emerson P.M., Lietman T.M., Keenan J.D. Latrine promotion for trachoma: assessment of mortality from a cluster-randomized trial in Ethiopia. Am. J. Trop. Med. Hyg. 2011, 85(3):518.
18. Hardin G. The tragedy of the commons. Science 1968, 162(5364):1243-1248.
19. Haug S., Lakew T., Habtemariam G., Alemayehu W., Cevallos V., Zhou Z., House J., Ray K., Porco T., Rutar T., Keenan J., Lietman T., Gaynor B. The decline of pneumococcal resistance after cessation of mass antibiotic distributions for trachoma. Clin. Infect. Dis. 2010, 51(5):571-574.
20. Hersh A.L., Shapiro D.J., Pavia A.T., Shah S.S. Antibiotic prescribing in ambulatory pediatrics in the United States. Pediatrics 2011, 128(6):1053-1061.
21. Hong K.C., Schachter J., Moncada J., Zhou Z., House J., Lietman T.M. Lack of macrolide resistance in Chlamydia trachomatis after mass azithromycin distributions for trachoma. Emerg. Infect. Dis. 2009, 15(7):1088-1090.
22. Howden B.P., Peleg A.Y., Stinear T.P. The evolution of vancomycin intermediate Staphylococcus aureus (VISA) and heterogenous-VISA. Infect. Genet. Evol. 2014, 21(0):575-582. http://dx.doi.org/10.1016/j.meegid.2013.03.047.
23. Keeling M.J., Rohani P. Modeling Infectious Diseases in Humans and Animals 2008, Princeton University, Princeton.
24. Keenan J.D., Ayele B., Gebre T., Zerihun M., Zhou Z., House J.I., Gaynor B.D., Porco T.C., Emerson P.M., Lietman T.M. Childhood mortality in a cohort treated with mass azithromycin for trachoma. Clin. Infect. Dis. 2011, 52(7):883-888.
25. Keenan J.D., Emerson P.M., Gaynor B.D., Porco T.C., Lietman T.M. Adult mortality in a randomized trial of mass azithromycin for trachoma. JAMA Intern. Med. 2013, 173(9):821-823.
26. Lawi G., Mugisha J., Omolo-Ongati N. Mathematical model for malaria and meningitis co-infection among children. Appl. Math. Sci. 2011, 5(47):2337-2359.
27. Laxminarayan R., Duse A., Wattal C., Wattal A.K., Wertheim H.F., Sumpradit N., Vlieghe E., Hara G.L., Gould I.M., Goossens H., et al. Antibiotic resistance the need for global solutions. Lancet Infect. Dis. 2013, 13(12):1057-1098.
28. Leach A.J., Shelby-James T.M., Mayo M., Gratten M., Laming A.C., Currie B.J., Mathews J.D. A prospective study of the impact of community-based azithromycin treatment of trachoma on carriage and resistance of Streptococcus pneumoniae. Clin. Infect. Dis. 1997, 24(3):356-362.
29. Lloyd W.F. Two Lectures on the Checks to Population 1833, Oxford University Press, Oxford, England.
30. MacDougall C., Polk R.E. Antimicrobial stewardship programs in health care systems. Clin. Microbiol. Rev. 2005, 18(4):638-656.
31. Maher M.C., Alemayehu W., Lakew T., Gaynor B.D., Haug S., Cevallos V., Keenan J.D., Lietman T.M., Porco T.C. The fitness cost of antibiotic resistance in Streptococcus pneumoniae: insights from the field. PLoS ONE 2012, 7(1):e29407.
32. Massad E., Burattini M.N., Coutinho F.A.B., Yang H.M., Raimundo S.M. Modeling the interaction between AIDS and tuberculosis. Math. Comput. Model. 1993, 17(9):7-21.
33. McCarthy A.J., Lindsay J.A. The distribution of plasmids that carry virulence and resistance genes in Staphylococcus aureus is lineage associated. BMC Microbiol. 2012, 12(1):104.
34. Mukandavire Z., Gumel A., Garira W., Tchuenche J. Mathematical analysis of a model for HIV-malaria co-infection. Math. Biosci. Eng. 2009, 6(2):333-359.
35. Mushayabasa S., Tchuenche J., Bhunu C., Ngarakana-Gwasira E. Modeling gonorrhea and HIV co-interaction. BioSystems 2011, 103(1):27-37.
36. Neu H.C. The crisis in antibiotic resistance. Science 1992, 257(5073):1064-1073.
37. O'Connor K.A., Kingston M., O'Donovan M., Cryan B., Twomey C., O'Mahony D. Antibiotic prescribing policy and Clostridium difficile diarrhoea. QJM 2004, 97(7):423-429.
38. Porco T.C., Gao D., Scott J.C., Shim E., Enanoria W.T., Galvani A.P., Lietman T.M. When does overuse of antibiotics become a tragedy of the commons?. PloS ONE 2012, 7(12):e46505.
39. Porco T.C., Gebre T., Ayele B., House J., Keenan J., Zhou Z., Hong K.C., Stoller N., Ray K.J., Emerson P., Gaynor B.D., Lietman T.M. Effect of mass distribution of azithromycin for trachoma control on overall mortality in Ethiopian children: a randomized trial. JAMA 2009, 302(9):962-968.
40. Pressley J., D'Agata E.M.C., Webb G.F. The effect of co-colonization with community-acquired and hospital-acquired methicillin-resistant Staphylococcus aureus strains on competitive exclusion. J. Theor. Biol. 2010, 264(3):645-656.
41. Pulcini C., Gyssens I.C. How to educate prescribers in antimicrobial stewardship practices. Virulence 2013, 4(2):192-202.
42. Reluga T.C., Galvani A.P. A general approach for population games with application to vaccination. Math. Biosci. 2011, 230(2):67-78.
43. Roeger L., Feng Z., Castillo-Chavez C. Modeling TB and HIV co-infections. Math. Biosci. Eng. 2009, 6(4):815-837.
44. Schachter J., West S.K., Mabey D., Dawson C.R., Bobo L., Bailey R., Vitale S., Quinn T.C., Sheta A., Sallam S., Mkocha H., Mabey D., Faal H. Azithromycin in control of trachoma. Lancet 1999, 354(9179):630-635.
45. Sharomi O., Podder C., Gumel A., Song B. Mathematical analysis of the transmission dynamics of HIV/TB coinfection in the presence of treatment. Math. Biosci. Eng. 2008, 5(1):145.
46. Simell B., Auranen K., Käyhty H., Goldblatt D., Dagan R., O'Brien K. The fundamental link between pneumococcal carriage and disease. Expert Rev. Vac. 2012, 11(7):841-855.
47. Skalet A., Cevallos V., Ayele B., Gebre T., Zhou Z., Jorgensen J., Zerihun M., Habte D., Assefa Y., Emerson P., Gaynor B., Porco T., Lietman T., Keenan J. Antibiotic selection pressure and macrolide resistance in nasopharyngeal Streptococcus pneumoniae: a cluster-randomized clinical trial. PLoS Med. 2010, 7(12):e1000377.
48. Smith H.L. Monotone Dynamical Systems: An Introduction to the Theory of Competitive and Cooperative Systems 1995, 41. American Mathematical Society, Providence, RI.
49. Solomon A.W., Mohammed Z., Massae P.A., Shao J.F., Foster A., Mabey D.C.W., Peeling R.W. Impact of mass distribution of azithromycin on the antibiotic susceptibilities of ocular Chlamydia trachomatis. Antimicrob. Agents Chemother. 2005, 49(11):4804-4806.
50. Spellberg B., Blaser M., Guidos R., Boucher H., Bradley J., Eisenstein B., Gerding D., Lynfield R., Reller L., Rex J., Schwartz D., Septimus E., Tenover F., Gilbert D. Combating antimicrobial resistance: policy recommendations to save lives. Clin. Infect. Dis. 2011, 52(Suppl. 5):S397-S428.
51. van den Driessche P., Watmough J. Reproduction numbers and sub-threshold endemic equilibria for compartmental models of disease transmission. Math. Biosci. 2002, 180(2):29-48.
52. WHO Progress report on elimination of trachoma, 2010. Wkly. Epidemiol. Rec. 2012, 87:161-168.